Evidence map›Paper›PMID 34806797›Full record

ArticleHematological oncology2022

Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.

Hanyin Wang, Shulan Tian, Qing Zhao, Wendy Blumenschein, Jennifer H Yearley, Charla R Secreto, Sutapa Sinha, Timothy G Call, Yucai Wang, Sameer A Parikh and 10 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Hematological oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Hanyin WangDepartment of Hospital Internal Medicine, Mayo Clinic Health System, Mankato, Minnesota, USA.ORCID 0000-0001-7649-0892
Shulan TianDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Qing ZhaoBiostatistics and Research Decision Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Wendy BlumenscheinGenome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Jennifer H YearleyGenome and Biomarker Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Charla R SecretoDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Sutapa SinhaDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Timothy G CallDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Yucai WangDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-1576-8341
Sameer A ParikhDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-3221-7314
Saad S KenderianDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6116-8163
Jose F LeisDivision of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
Min ShiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-5741-4293
Daniel L Van DykeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Neil E KayDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Esteban BraggioDivision of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
Huihuang YanDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Wei DingDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-9811-4601

Funding

Merck & Co., Inc.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellTranscriptomeAdenineHumansPiperidinesAdenineibrutinibPiperidines

Identifiers

PMID34806797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.